Felix A. Westcott

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night.

Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night.

Journal: Cell metabolism

Published: April 03, 2026

Physiologically relevant media are associated with overlapping metabolic responses in primary human hepatocytes and Huh7 cells.

Physiologically relevant media are associated with overlapping metabolic responses in primary human hepatocytes and Huh7 cells.

Journal: Physiological reports

Published: February 17, 2026

Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night.

Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night.

Journal: Cell metabolism

Published: March 27, 2025

Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans.

Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans.

Journal: Disease models & mechanisms

Published: January 29, 2025

Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans.

Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans.

Journal: European journal of endocrinology

Published: January 29, 2024

Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk.

Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk.

Journal: Atherosclerosis

Published: June 12, 2023

Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.

Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.

Journal: European journal of endocrinology

Published: August 17, 2021

Risk factors associated with post-operative uveitis after cataract surgery: a retrospective case-control study.

Risk factors associated with post-operative uveitis after cataract surgery: a retrospective case-control study.

Journal: Eye (London, England)

Published: October 21, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026